Your browser doesn't support javascript.
loading
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Dooley, Kelly E; Hendricks, Bronwyn; Gupte, Nikhil; Barnes, Grace; Narunsky, Kim; Whitelaw, Colleen; Smit, Tanya; Ignatius, Elisa H; Friedman, Adine; Dorman, Susan E; Dawson, Rodney.
Afiliación
  • Dooley KE; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hendricks B; Division of Pulmonology, Department of Medicine and University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Gupte N; Johns Hopkins India Private Limited, Pune, India.
  • Barnes G; School of Medicine, Johns Hopkins University, Baltimore, Maryland; and.
  • Narunsky K; Division of Pulmonology, Department of Medicine and University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Whitelaw C; Division of Pulmonology, Department of Medicine and University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Smit T; Division of Pulmonology, Department of Medicine and University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Ignatius EH; School of Medicine, Johns Hopkins University, Baltimore, Maryland; and.
  • Friedman A; Division of Pulmonology, Department of Medicine and University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Dorman SE; Medical University of South Carolina, Charleston, South Carolina.
  • Dawson R; Division of Pulmonology, Department of Medicine and University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa.
Am J Respir Crit Care Med ; 207(7): 929-935, 2023 04 01.
Article en En | MEDLINE | ID: mdl-36455068

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Nitroimidazoles Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Animals Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Nitroimidazoles Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Animals Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article